John Wanebo, MD
Neurological Surgery · Scottsdale, AZNPI 1588625313
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $25,405 of the $34,719 with a category attached, or 73.2%. Zimmer Biomet accounts for 79.8% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2019 at $21,286 and has fallen 99.6% since, to $88 in 2025.
Across 46 payments — averaging $754.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$28K
- GT Medical Technologies, Inc$5K
- Globus Medical$488
- Providence Medical Technology, Inc.$394
- Orthofix Medical, Inc.$262
- Omniscient Neurotechnology America Ltd$215
- plus $402 from 7 others
Across 156 payments — averaging $2532.93 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GT Medical Technologies, Inc$297K
- Arbor Pharmaceuticals, Inc.$79K
- Azurity Pharmaceuticals, Inc.$19K
What the payments were for
- Royalty or licence$25,40573%
- Consulting fees$5,25015%
- Travel & lodging$1,4064%
- Food & beverage$2,6588%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 9 | $27,702 |
| GT Medical Technologies, Inc | 14 | $5,255 |
| Globus Medical(2 entities) | 6 | $488 |
| Providence Medical Technology, Inc. | 5 | $394 |
| Orthofix Medical, Inc. | 2 | $262 |
| Omniscient Neurotechnology America Ltd | 2 | $215 |
| Elekta, Inc. | 1 | $100 |
| Monteris Medical Corporation | 1 | $100 |
| Seaspine Orthopedics Corporation | 1 | $88 |
| Medtronic | 2 | $58 |
| Pfizer | 1 | $25 |
| Abbott | 1 | $17 |
| Kuros Biosciences USA, Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Alta$25,579
- GammaTile$4,927
- ROSA-Brain$2,000
- ExcelsiusGPS Robotic Navigation System$221
- CORBEL$185
- M6-C$176
- Quicktome$136
- ROSA Spine$123
- Unity$100
- Mosaiq$100
- Versa HD$100
- METRIQ$100
- SYNERGY$100
How this compares
$34,719 in reported general payments places this provider in the 75th percentile of 173 neurological surgery providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 102 | $1,585 |
| Pregabalin | 27 | $455 |
| Alprazolam | 14 | $348 |
| Cyclobenzaprine Hcl | 28 | $283 |
| Celecoxib | 13 | $228 |
| ClopidogrelClopidogrel Bisulfate | 13 | $207 |
| Tramadol Hcl | 16 | $182 |
| Methylprednisolone | 16 | $117 |
| Lorazepam | 12 | $11 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Scottsdale
- Frederick MarcianoScottsdale$809K
- Maziyar KalaniScottsdale$334K
- Abhineet ChowdharyScottsdale$279K
- Peter NakajiScottsdale$160K
- Luis TumialanScottsdale$81K
- Abhishiek SharmaScottsdale$27K
- Igor YusupovScottsdale$14K
- Robert SpetzlerPhoenix$12.8M
- Juan UribePhoenix$6.7M
- Stephen PapadopoulosPhoenix$6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.